Kate O’Kelly-Lynch joined Blue Matter in 2022, bringing over seven years of life sciences experience spanning consulting and market access. She has extensive experience with market access landscape assessments and pricing research, product strategy, customer segmentation and engagement strategy, and organizational strategy. Her content expertise spans oncology (solid tumors and hematology), cardiovascular and metabolic disease, and neurological diseases.

Kate holds a B.A. in Economics and Biology from Boston College.